3-10249587-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6BP7
The NM_014760.4(TATDN2):āc.387T>Gā(p.Ser129Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000241 in 1,529,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: š 0.00012 ( 0 hom., cov: 33)
Exomes š: 0.00025 ( 0 hom. )
Consequence
TATDN2
NM_014760.4 synonymous
NM_014760.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.615
Genes affected
TATDN2 (HGNC:28988): (TatD DNase domain containing 2) Predicted to enable metal ion binding activity and nuclease activity. Predicted to be involved in nucleic acid phosphodiester bond hydrolysis. Predicted to be located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 3-10249587-T-G is Benign according to our data. Variant chr3-10249587-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 3053761.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.615 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TATDN2 | NM_014760.4 | c.387T>G | p.Ser129Ser | synonymous_variant | 2/8 | ENST00000448281.7 | NP_055575.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TATDN2 | ENST00000448281.7 | c.387T>G | p.Ser129Ser | synonymous_variant | 2/8 | 1 | NM_014760.4 | ENSP00000408736.2 | ||
TATDN2 | ENST00000287652.8 | c.387T>G | p.Ser129Ser | synonymous_variant | 2/8 | 1 | ENSP00000287652.4 | |||
ENSG00000272410 | ENST00000437082.5 | n.216T>G | non_coding_transcript_exon_variant | 1/8 | 2 | ENSP00000402783.1 | ||||
ENSG00000272410 | ENST00000450534.1 | n.216T>G | non_coding_transcript_exon_variant | 1/8 | 2 | ENSP00000399689.1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152188Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
18
AN:
152188
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000189 AC: 34AN: 180234Hom.: 0 AF XY: 0.000198 AC XY: 19AN XY: 96184
GnomAD3 exomes
AF:
AC:
34
AN:
180234
Hom.:
AF XY:
AC XY:
19
AN XY:
96184
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000255 AC: 351AN: 1377372Hom.: 0 Cov.: 31 AF XY: 0.000235 AC XY: 159AN XY: 676868
GnomAD4 exome
AF:
AC:
351
AN:
1377372
Hom.:
Cov.:
31
AF XY:
AC XY:
159
AN XY:
676868
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000118 AC: 18AN: 152306Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74470
GnomAD4 genome
AF:
AC:
18
AN:
152306
Hom.:
Cov.:
33
AF XY:
AC XY:
9
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
TATDN2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 05, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at